Sabby Management’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-1,179
Closed -$735K 104
2022
Q4
$735K Buy
1,179
+999
+555% +$7.14K 0.64% 20
2022
Q3
$121K Buy
+180
New +$1.24K 0.15% 75
2019
Q1
Sell
-8,467
Closed -$38.9M 98
2018
Q4
$38.9M Buy
8,467
+1,775
+27% +$85.5K 8.57% 3
2018
Q3
$29.7M Sell
6,692
-296
-4% -$13.6K 3.8% 6
2018
Q2
$27.4M Buy
6,988
+935
+15% +$47.2K 4.23% 8
2018
Q1
$43.8M Buy
6,053
+4,383
+262% +$322K 5.21% 5
2017
Q4
$11M Buy
1,670
+191
+13% +$10.3K 1% 20
2017
Q3
$7.41M Buy
1,479
+1,222
+475% +$58.9K 0.48% 28
2017
Q2
$1.19M Hold
257
0.08% 96
2017
Q1
$907K Buy
+257
New +$5.88K 0.05% 136
2015
Q3
Sell
-399
Closed -$3.26M 389
2015
Q2
$3.26M Buy
+399
New +$39.1K 0.12% 123

Other funds holding ESPR